Publication Name	World Journal of Methodology
Manuscript ID	84902
Country	Thailand

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Immunotherapy for advanced gastric cancer
Manuscript Source	Invited Manuscript
All Author List	Wattana Leowattana, Pathomthep Leowattana and Tawithep Leowattana
Funding Agency and Grant Number
Corresponding Author	Wattana Leowattana, BMed, MD, MSc, PhD, Full Professor, Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, 420/6 Rajavithi road, Tungphyathai, Rachatawee 10400, Bangkok, Thailand. wattana.leo@mahidol.ac.th
Key Words	Immunotherapy; Advanced gastric cancer; Personalized medicine; Biomarkers; Chemotherapy; Cancer vaccine
Core Tip	Throughout the globe, gastric cancer (GC) is ranked as the fifth most frequent cancer and the third most common cause of death. Chemotherapy, radiation, stomach resection, and targeted treatments are common treatment modalities. The development of immunotherapy for GC has already produced some encouraging outcomes and changed the treatment process. Currently, new immunotherapies that target novel molecules, as well as other combination treatments, have been developed. Immune checkpoint inhibitors are being used more and more often. In this review, we sought to examine the viewpoint, development, and reported clinical results of several immunotherapy treatment modalities for advanced GC patients.
Citation	Leowattana W, Leowattana P, Leowattana T. Immunotherapy for advanced gastric cancer. World J Methodol 2023; 13(3): 79-97

Received	2023-04-01 07:31
Peer-Review Started	2023-04-01 07:34
To Make the First Decision
Return for Revision	2023-05-05 01:13
Revised	2023-05-11 05:04
Second Decision	2023-05-30 03:18
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-05-31 00:52
Articles in Press	2023-05-31 00:52
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-06-12 15:16

ISSN	2222-0682 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com